Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
Acta Oncol. 2012 Mar;51(3):333-44. doi: 10.3109/0284186X.2011.618510. Epub 2011 Dec 16.
Loco-regional radiotherapy of left-sided breast cancer represents a treatment planning challenge when the internal mammary chain (IMC) lymph nodes are included in the target volume. This treatment planning study evaluates the reduction in cardiopulmonary doses when radiation is given during deep inspiration breath-hold (DIBH). This was achieved without compromising dose coverage to the planning target volume (PTV).
Seventeen patients with early breast cancer, referred for adjuvant radiotherapy, were included. For each patient two computed tomography (CT)-scans were acquired; the first during free breathing (FB) and the second during DIBH. The scans were monitored by the Varian RPM respiratory gating system. Audio-visual guidance was used. The treatment planning of the two CT studies was performed focusing on good coverage (V95% > 98%) of the PTV. Doses to the heart, left anterior descending (LAD) coronary artery, lungs and contralateral breast were assessed.
With equal PTV coverage, average mean heart dose was reduced from 6.2 Gy to 3.1 Gy in DIBH plans as compared to FB. Average volume receiving 25 Gy or more (V25Gy) was reduced from 6.7% to 1.2%, and the number of patients with V25Gy > 5% was reduced from 8 to 1 utilizing DIBH. The average mean dose to the LAD coronary artery was reduced from 25.0 Gy to 10.9 Gy. The average ipsilateral lung volume receiving 20 Gy or more (V20Gy) was reduced from 44.5% to 32.7% with DIBH. In 11 of the DIBH plans V20Gy was lower than 35%, in accordance with national guidelines, while none of the FB plans fulfilled this recommendation.
Respiratory gated radiotherapy during DIBH is a suitable technique for loco-regional breast irradiation even when IMC lymph nodes are included in the PTV. Cardiopulmonary doses are considerably decreased for all dose levels without compromising the dose coverage to PTV.
当左侧乳腺癌的靶区包括内乳链(IMC)淋巴结时,局部区域放疗代表了一种治疗计划的挑战。本研究通过深吸气屏气(DIBH)放疗,评估了心肺剂量的降低。在不影响计划靶区(PTV)剂量覆盖的情况下实现了这一点。
纳入 17 例早期乳腺癌患者,行辅助放疗。每位患者进行两次 CT 扫描;第一次在自由呼吸(FB)时进行,第二次在 DIBH 时进行。扫描由瓦里安 RPM 呼吸门控系统监测。使用视听引导。两次 CT 研究的治疗计划都侧重于 PTV 的良好覆盖(V95%>98%)。评估了心脏、左前降支(LAD)冠状动脉、肺和对侧乳房的剂量。
在 PTV 覆盖相等的情况下,与 FB 相比,DIBH 计划中的平均心脏剂量从 6.2Gy 降低至 3.1Gy。接受 25Gy 或更高剂量(V25Gy)的平均体积从 6.7%降低至 1.2%,V25Gy>5%的患者人数从 8 人减少至 1 人。LAD 冠状动脉的平均平均剂量从 25.0Gy 降低至 10.9Gy。DIBH 可使同侧肺接受 20Gy 或更高剂量(V20Gy)的平均体积从 44.5%降低至 32.7%。11 例 DIBH 计划中的 V20Gy 低于 35%,符合国家指南,而 FB 计划中没有一个符合这一建议。
即使 IMC 淋巴结包含在 PTV 中,DIBH 下的呼吸门控放疗也是局部区域乳腺照射的一种合适技术。在不影响 PTV 剂量覆盖的情况下,所有剂量水平的心肺剂量都显著降低。